Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Germany's Merck KGaA insists chip market remains attractive

Published 20/10/2022, 13:03
© Reuters. FILE PHOTO: A logo of drugs and chemicals group Merck KGaA is pictured in Darmstadt, Germany January 28, 2016.  REUTERS/Ralph Orlowski
MRK
-
MRCG
-
MKKGY
-
MRCK34
-
CHNA
-

By Ludwig Burger and Natalie Grover

FRANFURT/LONDON (Reuters) -Merck KGaA does not anticipate that a projected decline in smartphone sales this year will weigh on its semiconductor chemicals business, CEO Belen Garijo told Reuters on Thursday, insisting the market remained attractive.

Sales of mobile phones, the biggest driver of the microchip market, are forecast to fall 7.1% this year amid economic uncertainty and a cost of living crisis.

Besides making pharmaceuticals and lab equipment, family-controlled German conglomerate Merck supplies chemicals and materials used in making semiconductors.

There is a significant shortage of chips and Merck's customers are ramping up capacity for the future but there is currently a softening in smartphone demand, Garijo said.

"We believe that this is a transitory impact," she said, adding that chips are used across industry, from automotives to data storage and beyond which keeps the sector attractive.

"We don't hear anything that should be questioning the attractiveness of the semiconductor market."

Competing with rivals including Entegris, Samsung (LON:0593xq) SDI and DuPont (NYSE:DD), Merck's Electronics division owes its current size mainly to takeovers of AZ Electronics in 2014 and Versum Materials in 2019.

Merck's Electronics division has benefited from a global investment push to end the chip shortage. During the second quarter, it saw sales increase by a currency-adjusted 7.4% to close to 1 billion euros, driven by a 20% gain in business with semiconductor makers.

Garijo's bullish outlook is similar to that of ASML, a key equipment supplier to computer chip manufacturers, which this week said customers were focusing on long-term plans rather than the current economic slowdown, although analysts have been more cautious.Meanwhile, Merck's investment strategy in China has not changed but it is "mindful of the potential risks", Garijo noted in the Reuters Newsmaker interview.

China is a key region for the semiconductor industry and drug companies, but geopolitical challenges are growing. While Taiwan has lived under the Chinese threat for decades, war games in early August have rattled nerves.

© Reuters. FILE PHOTO: A logo of drugs and chemicals group Merck KGaA is pictured in Darmstadt, Germany January 28, 2016.  REUTERS/Ralph Orlowski

There is a need for "constructive dialogue" with markets like China that are important to German industry, and Merck, said Garijo.

"We are mindful of the potential risks ... but our investment policy has not changed," she said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.